Comprehensive Genomic profiling (CGP) is becoming standard of care in oncology. It allows clinicians to maximize clinical information from limited biopsy samples so that patients are matched with approved therapies or enrolled in relevant clinical trials.

In this workshop, our panel will describe the implementation of a CGP assay at their institutions. They will also discuss how flexible automation, sample batching, data analysis and reporting solutions are key to offer CGP testing so that data access and turn-around time can benefit patients.

Learn:

• Reasons to implement and value of a flexible future-proof DNA+RNA CGP assay.
• The impact of reflex CGP testing on testing decision trees and workflow consolidation.
• Value of sample management and genomic literacy for oncologists and molecular tumor boards.

Moderator:

Sue Beruti, MD, MHA
Sr. Medical Director,
Clinical Genomics
Illumina

Speakers:

Nikoletta Sidiropoulos, MD
Associate Professor & Director Molecular Pathology
University of Vermont
Larner College of Medicine

Jeffrey Conroy
Chief Scientific Officer and Director Genomics Technologies
OmniSeq Inc., Roswell Park Comprehensive Cancer Center

Jeremy Wallentine, MD
Pathologist
Intermountain Health